What is CORT's P/E ratio?

CORCEPT THERAPEUTICS INCORPORATED (CORT) currently trades at a P/E ratio of 101.63.

CORCEPT THERAPEUTICS INCORPORATED reports a Return on Equity (ROE) of 7.51%.

What is CORT's dividend yield?

CORCEPT THERAPEUTICS INCORPORATED offers a dividend yield of 0.00%.

What is CORT's Deepscope Quality Score?

Deepscope rates CORT's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy CORT?

Deepscope's AI Timing Score for CORT is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does CORT belong to?

CORCEPT THERAPEUTICS INCORPORATED is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

CORT (NASDAQ) Stock Analysis | CORCEPT THERAPEUTICS INCORPORATED

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-05 | FS: 2026-03-31)

CORT

CORCEPT THERAPEUTICS INCORPORATED

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 72.62

-2.27 (-3.03%) Day Change

Watchlist Portfolio Compare Chart

101.63

P/E

0.00

D/E

7.5%

ROE

5.9%

ROA

0.00%

Div Yield

53.49

PEG

CORCEPT THERAPEUTICS INCORPORATED
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 72.62 Price -2.27 (-3.03%) Day Change	NEWS SCORE: 99

CORT, the overall quality is not good ( Quality = 31) but the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/E ratio is relatively high
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	1837
Magic Formula Rank by ROE	1837
Magic Formula Rank by ROIC	2540
Price	72.62
PBV / Sector	12.60 / 4.63
Earning Per Share	0.43

PE / Sector	101.63 / 17.43
PEG or PE/Growth / Sector	53.49 / 0.53
Average 1M Daily Value	62.59 M
Average 1W Daily Value	57.91 M

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

58%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	6.23 / 449.48
NPM Average (%) / Sector	17.45 / -1,506.49 GREAT
NPM Change Average (%) / Sector	-26.98 / 4,940.99
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	5.88 / 30.58
ROA Average (%) / Sector	13.77 / -347.17
ROA Change Average (%) / Sector	-20.85 / 5,125.52
ROE (%) / Sector	7.51 / -3.58
ROE Average (%) / Sector	16.92 / 40.65
ROE Change Average (%) / Sector	-18.64 / 2,109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.17

Registration Details

Analyze Date	2026-06-06 09:08:49
Symbol	CORT
Name	CORCEPT THERAPEUTICS INCORPORATED
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	107.35 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	8,039.56 / 8,857.28

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 101 Redwood Shores Parkway, Redwood City, CA, United States, 94065

Phone: 650 327 3270

Website: https://www.corcept.com

Employees: 730

Sector: Healthcare >> Biotechnology

Description: Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. It also develops relacorilant, a selective cortisol modulator for patients with hypercortisolism; a selective cortisol modulator miricorilant, which is in Phase 1b trial for metabolic dysfunction-associated steatohepatitis; and a portfolio of proprietary selective cortisol modulators, such as relacorilant, nenocorilant, miricorilant, and dazucorilant for the treatment of Lou Gehrig's disease. The company was incorporated in 1998 and is headquartered in Redwood City, California.